NCT05176223 2026-02-05
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer
Mayo Clinic
Phase 2 Completed
Clinical Trials
10 trialsNCT04762888 2025-10-31
68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer
Mayo Clinic
Phase 2 Completed
NCT06521775 2025-09-12
An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma
Mayo Clinic
Phase 2 Completed
NCT03396874 2023-11-03
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
University of Michigan
Phase 2 Completed
NCT04179968 2023-03-20
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT04050215 2021-09-30
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT03515577 2020-10-14
PSMA vs AXUMIN
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT03675451 2020-10-14
PSMA Imaging of Localized Prostate Cancer
Weill Medical College of Cornell University
Phase 2 Completed
NCT03207139 2019-07-17
Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer
Chang Gung Memorial Hospital
Phase 2 Completed